retatrutide human studies Retatrutide—A Game Changer in Obesity

Pain scores on the standard knee-osteoarthritis outcome measure (the WOMAC pain subscale) fell by an average of 4.5 points, around 75.8%

Purity consistently reaches 99.5%+ , confirmed by HPLC and mass spectrometry

Central Nervous System Appetite Modulation GLP-1 signaling also influences neural pathways involved in hunger and reward processing, as documented in clinical pharmacology research published in the NCBI [2] literature on incretin-based therapies

Tornehave, et al (2008)

Patients with T2DM, persons at risk for AD, had a significantly lower associated risk of AD after administered exenatide, liraglutide and dulaglutide ( Conclusion Increasing evidence suggests that anti-diabetes medicine, GLP-1R agonists, have multiple neuroprotective mechanisms in AD models, such as anti-inflammation, anti-oxidative stress, reducing A aggregation/deposition and tau protein hyperphosphorylation, reducing neuronal apoptosis and neurotoxicity, increasing cell proliferation and neurogenesis, increasing synaptic plasticity, and other beneficial effects

Syra Hanif M.D